BPC-157 dosage
Also known as: body protection compound
What is BPC-157?
BPC-157 is a lab-made peptide (a short chain of 15 amino acids) described as a fragment of a protective protein found in human stomach juice. It was first reported in the early 1990s and is not an approved medicine in any country.
How it works
How it works is not established. In animal and cell studies it is proposed to raise growth-factor signaling, encourage new blood vessel growth, boost nitric oxide and lower inflammatory signals, but FDA reviewers note its molecular target has not been identified.
What the evidence shows
Nearly all the evidence comes from rats and cell cultures: a 2025 systematic review of musculoskeletal research found 35 preclinical studies and one human study. FDA reviewers found five small human studies in total, including an uncontrolled knee-injection series, a 12-person bladder pilot and a 2-person intravenous pilot. The only placebo-controlled trial, in 53 people with ulcerative colitis, was reported only as a meeting abstract and showed no clear difference from placebo. A phase 1 trial of oral tablets registered in 2015 never posted results. There are no completed human efficacy trials for tendon, muscle or joint injury, and long-term safety is unknown.
Reported side effects
- Human safety data are very limited: small, short studies with little safety monitoring
- Headache and flatulence in enema studies in healthy volunteers
- Injection-site redness and swelling (FDA adverse event report)
- Shortness of breath leading to an emergency visit (single FDA report, cause unconfirmed)
- Skin and gum darkening with a combined BPC-157 and TB-500 product (single FDA report)
Cautions
- FDA says injectable BPC-157 may trigger unwanted immune reactions because of peptide clumping and impurities.
- Products sold online as research chemicals are not regulated for quality or purity.
- Reviewers raise a theoretical concern that promoting blood vessel growth could support tumor growth; this is untested in people.
- Every published human study reported benefit, which reviewers say suggests publication bias.
Legal and regulatory status
BPC-157 is not FDA-approved for any use. FDA lists it among compounding substances that may present significant safety risks. In July 2026 an FDA advisory committee voted to recommend allowing pharmacy compounding, against the proposal of FDA's own reviewers; as of October 2026 FDA had not acted on that vote. It is prohibited at all times in sport under section S0 (non-approved substances) of the WADA Prohibited List.
Common questions
Is BPC-157 FDA approved?
No. FDA reviewers state there is no approved product containing BPC-157 in any country. The July 2026 advisory vote on pharmacy compounding is not a drug approval, and FDA has not made a final decision.
Does BPC-157 actually work in humans?
That has not been shown. Human evidence consists of a handful of small, mostly uncontrolled studies, and the one placebo-controlled trial did not show a clear benefit.
Is BPC-157 banned in sports?
Yes. The WADA Prohibited List names BPC-157 under S0, non-approved substances, which are banned in and out of competition.
Sources
- FDA: Evaluation of BPC-157 for the Pharmacy Compounding Advisory Committee, July 2026
- FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
- FDA: PCAC briefing document introduction, July 23-24, 2026
- Mintz: FDA's advisory committee votes on peptides, what it does and does not change
- HSS Journal: Emerging Use of BPC-157 in Orthopaedic Sports Medicine, a systematic review (2025)
- Current Reviews in Musculoskeletal Medicine: Regeneration or Risk? A narrative review of BPC-157 (2025)
- ClinicalTrials.gov: NCT02637284, phase 1 safety and pharmacokinetics trial of oral BPC-157
- USADA: BPC-157, a prohibited peptide and an unapproved drug
- WADA: 2026 Prohibited List (copy hosted by the Czech National Sports Agency)
BPC-157 reviews and Q&A
No reviews or questions yet. Be the first.
Get the printable dosing chart
All 50 peptides on a few pages, as a PDF. We’ll also email you when a peptide’s approval status or dosing changes.
More in Healing & recovery
Stacks that include BPC-157
Compare BPC-157
Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.